Diego Sait Cruz-Hernández

Dr. Diego Sait Cruz-Hernández

Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca, Mexico
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
FPFRANCISCO JAVIER SANCHEZ PEÑA
FRANCISCO JAVIER SANCHEZ PEÑA
MRMaria de los Angeles Romero-Tlalolini
Maria de los Angeles Romero-Tlalolini
HTHonorio Torres-Aguilar
Honorio Torres-Aguilar
Diego Sait Cruz-HernándezDiego Sait Cruz-Hernández
Diego Sait Cruz-Hernández
RBRafael Baltiérrez-Hoyos
Rafael Baltiérrez-Hoyos
SASergio R Aguilar-Ruiz
Sergio R Aguilar-Ruiz
Platelets play a crucial role in hemostasis and the immune response, mainly by recognizing signals associated with vascular damage. However, it has recently been discovered that the antimicrobial peptide LL-37 activates platelets in functions related to thrombus formation and inflammation. Therefore, this work aims to evaluate the effect of LL-37 on the activation of antimicrobial functions of human platelets. Our results show that platelets treated with LL-37 increase the surface expression of receptors (Toll-like receptors (TLRs) 2 and -4, CD32, CD206, Dectin-1, CD35, LOX-1, CD41, CD62P, and αIIbβ3 integrins) for the recognition of microorganisms, and molecules related to antigen presentation to T lymphocytes (CD80, CD86, and HLA-ABC) secrete the antimicrobial molecules: bactericidal/permeability-increasing protein (BPI), azurocidin, human neutrophil peptide (HNP) -1, and myeloperoxidase. They also translate azurocidin, and have enhanced binding to Escherichia coli, Staphylococcus aureus, and Candida albicans. Furthermore, the supernatant of LL-37-treated platelets can inhibit E. coli growth, or platelets can employ their LL-37 to inhibit microbial growth. In conclusion, these findings demonstrate that LL-37 participates in the antimicrobial function of human platelets.

Verified
Journal Article
Open access
PDF file
Alba Soledad Aquino-DominguezAlba Soledad Aquino-Dominguez
Alba Soledad Aquino-Dominguez
Victor Acevedo-SánchezVictor Acevedo-Sánchez
Victor Acevedo-Sánchez
Diego Sait Cruz-HernándezDiego Sait Cruz-Hernández
Diego Sait Cruz-Hernández
SSSaraí Sánchez-Aparicio
Saraí Sánchez-Aparicio
MRMaria de los Angeles Romero-Tlalolini
Maria de los Angeles Romero-Tlalolini
SASergio R Aguilar-Ruiz
Sergio R Aguilar-Ruiz
Platelets play a significant role in hemostasis and perform essential immune functions, evidenced by the extensive repertoire of antimicrobial molecules. Currently, there is no clear description of the presence of azurocidin in human platelets. Azurocidin is a 37 kDa cationic protein abundant in neutrophils, with microbicidal, opsonizing, and vascular permeability-inducing activity. Therefore, this work aimed to characterize the content, secretion, translation, and functions of azurocidin in platelets. Our results show the presence of azurocidin mRNA and protein in α-granules of platelet and megakaryoblasts, and stimulation with thrombin, ADP, and LPS leads to the secretion of free azurocidin as well as within extracellular vesicles. In addition, platelets can translate azurocidin in a basal or thrombin-induced manner. Finally, we found that the addition of low concentrations of azurocidin prevents platelet aggregation and activation. In conclusion, we demonstrate that platelets contain, secrete, and translate azurocidin, and this protein may have important implications for hemostasis.

1 April 2026 in PLOS ONE
Verified
Journal Article
Open access
MSMarcos Alvarado Silva
Marcos Alvarado Silva
TJTannya Karen Castro Jimenez
Tannya Karen Castro Jimenez
EKEdwin Antonio Lopez Kelly
Edwin Antonio Lopez Kelly
NLNallely Diaz Lima
Nallely Diaz Lima
JLJosé Alberto San Juan Luis
José Alberto San Juan Luis
José Bustos-ArriagaJosé Bustos-Arriaga
José Bustos-Arriaga
Dengue virus infection is a major global health problem with clinical outcomes ranging from mild febrile illness to severe disease. Although a reduction in platelet counts is a common feature of dengue, the mechanisms underlying the presence of viral antigens in circulating platelets remain incompletely understood. In this study, we investigated whether infection of megakaryocytic precursors contributes to the generation of platelets carrying dengue virus proteins. Using the human megakaryocytic precursor cell lines K562 and MEG-01 cell lines as in vitro models, we show that reference strains and clinical isolates of dengue virus infect megakaryocytic precursors and modulate their differentiation, as evidenced by increased expression of the differentiation marker CD41 and the production of platelet-like particles. Flow cytometry analysis demonstrated that PLPs released from infected precursors contained precursor-derived PLP-associated dengue virus envelope protein. Correlation analyses revealed significant associations between the extent of precursor infection and both differentiation markers and PLP-associated E protein levels at early time points. Consistent with these findings, dengue virus E protein was detected in platelets from dengue patients, while no statistically significant differences were observed between clinical severity groups, a trend toward higher proportions of E + platelets were observed in patients with dengue with warning signs or severe dengue. Spearman correlation analyses further supported an association between in vitro precursor infection and the generation of E-positive PLPs. In contrast, platelets from healthy donors incubated ex vivo with dengue virus did not acquire E protein, indicating that direct uptake or infection of circulating platelets is inefficient. Together, these results support a model in which infection of megakaryocytic precursors contributes to the generation of platelets carrying dengue virus antigens, suggesting that platelet-associated E protein may reflect bone marrow involvement during dengue infection.

Verified
Journal Article
Open access
PDF file
Diego Sait Cruz-HernándezDiego Sait Cruz-Hernández
Diego Sait Cruz-Hernández
FPFRANCISCO JAVIER SANCHEZ PEÑA
FRANCISCO JAVIER SANCHEZ PEÑA
Marymar Cruz CruzMarymar Cruz Cruz
Marymar Cruz Cruz
Darío de Jesús Guillén-MoralesDarío de Jesús Guillén-Morales
Darío de Jesús Guillén-Morales
MSMartha Cristina Castillo Soriano
Martha Cristina Castillo Soriano
SASergio Roberto Aguilar-Ruíz
Sergio Roberto Aguilar-Ruíz
Dengue virus (DENV) affects not only peripheral immune cells but also hematopoietic progenitors in the bone marrow, particularly megakaryocytic precursors, which contribute to the thrombocytopenia characteristic of the disease. In this study, we evaluated the relationship between the differentiation status of the megakaryocytic lineage and its permissiveness and antiviral response to DENV. Our results demonstrate that the erythroid–megakaryocytic precursor (K562 cells) was more permissive to DENV infection than megakaryoblasts, as evidenced by immunofluorescence, flow cytometry, and quantification of viral particles. The antiviral response in K562 cells peaked at three days post-infection, with maximal expression of genes associated with the type I interferon (IFN-I) pathway. In vitro-induced differentiation of K562 cells reduced the initial susceptibility to DENV and enhanced the expression of Toll-like receptor 3 (TLR3) and the type I interferon receptor (IFNAR1), accelerating and intensifying IFN-β secretion, and increasing the expression of OAS2 and IRF3. Furthermore, pretreatment of K562 cells with recombinant IFN-β significantly reduced viral replication from the first day post-infection. Collectively, these findings demonstrate for the first time that the differentiation status of erythroid–megakaryocytic progenitor critically shapes their antiviral response and underscore the central role of IFN-β in the early restriction of DENV infection.

27 July 2026 in Viruses
Verified
Journal Article
Open access
PDF file
TCTannya Karen Castro-Jiménez
Tannya Karen Castro-Jiménez
EKEdwin Antonio Lopez Kelly
Edwin Antonio Lopez Kelly
LCLeticia Cedillo-Barron
Leticia Cedillo-Barron
JCJulio García Cordero
Julio García Cordero
Diego Sait Cruz-HernándezDiego Sait Cruz-Hernández
Diego Sait Cruz-Hernández
José Bustos-ArriagaJosé Bustos-Arriaga
José Bustos-Arriaga
Orthoflaviviruses comprise genetically diverse mosquito-borne viruses responsible for a broad spectrum of human diseases. Although naturally circulating clinical isolates exhibit biological variability, the extent to which they generate distinct early epithelial innate immune responses remains incompletely understood. Here, we characterized five clinical orthoflavivirus isolates obtained in Oaxaca, Mexico, using human HaCaT keratinocytes as an in vitro model of early infection. Productive infection was assessed by immunofluorescence microscopy, immunostained focus appearance under isolate-optimized assay conditions, and infectious virus production, whereas host responses were evaluated by transcriptional profiling and quantitative whole-slide single-cell immunofluorescence. All isolates established productive infection and exhibited different viral replication profiles. Temporal transcriptional analyses revealed variable expression of antiviral (IFNβ, Mx1, OAS1, PKR, IFITM3, Viperin, and RANTES) and inflammatory (TNF-α, IL-8, and MCP-1) genes. Quantitative whole-slide analysis provided complementary evidence of variable STAT1 and NF-κB signaling activation across the analyzed isolates. Within this limited panel, viral replication was not consistently aligned with the selected transcriptional and signaling readouts, although the exploratory nature of these comparisons precludes establishing independence between these variables. Together, the virological, transcriptional, and imaging analyses revealed distinct multidimensional functional profiles across the isolate panel. Overall, these findings demonstrate functional heterogeneity among the analyzed clinical orthoflavivirus isolates and highlight integrated functional phenotyping as a useful framework for examining virus–host interactions beyond viral replication alone.

15 May 2022 in RA RIÓ GUENDARUYUBI
Verified
Journal Article
Open access
PDF file
Diego Sait Cruz-HernándezDiego Sait Cruz-Hernández
Diego Sait Cruz-Hernández
SSSaraí Remedios Sánchez-Aparicio
Saraí Remedios Sánchez-Aparicio
SRSergio Roberto Aguilar- Ruiz
Sergio Roberto Aguilar- Ruiz
Within innate immunity, the two major mechanisms of response to virus infections are: the synthesis of type I interferons (IFN-I) and the elimination of infected cells by NK lymphocytes. To produce type I interferons, it will be necessary for the cell to recognize the viral PAMPs through the PRR receptors found on the cell surface (TLR 4 and some CLRs), in the endosomes (TLR 3, 7, 8 and 9) or in the cytosol (RIG-I and MDA5), which may differ between different types of viruses. Following the production of IFNs-I, these will lead to the infected cell, as well as those nearby to mount an antiviral state, which will lead to the production of antiviral proteins to eradicate the infection. On the other hand, NK lymphocytes destroy virus-infected cells after sensing and recognizing that they no longer express MHC (major histocompatibility complex) class I molecules on their surface by releasing their cytotoxic mediators.